Dr. Cunningham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
95 Columbia St
Orlando, FL 32806Phone+1 407-849-9621Fax+1 407-420-4056- Is this information wrong?
Summary
- Research Experiences
Dr. Cunningham has extensive experience with research during his career. In medical school, he spent time at the National Eye Institute’s Laboratory of Ocular Immunology. During residency, he performed multiple research projects in the Ocular Surface Center at Baylor College of Medicine.
Dr. Cunningham has a particular interest in clinical trials. He currently serves as the Research Director at Florida Retina Institute, and is the Principal Investigator for multiple clinical trials including: Diabetic Retinopathy Clinical Research Network (DRCR) Protocol W, Protocol AC, and Protocol AD; Clearside TOPAZ Study; Allergan Phase 3 Abicipar Pegol; Chengdu Study for Neovascular Age-Related Macular Degeneration.
Doctor Cunningham holds a Bachelors of Science degree from the University of Florida and earned his medical degree, Cum Laude with Honors in Research, from the University of Florida College of Medicine.
He completed an internship and ophthalmology residency at Baylor College of Medicine. Following residency training, Dr. Cunningham completed a fellowship in vitreoretinal surgery and diseases at the University of Iowa Hospitals and Clinics.
Dr. Cunningham enjoys traveling, biking, cardiovascular and weight training. He also enjoys spending time with his wife, children and friends.
Doctor Cunningham joined Florida Retina Institute in 2013.
Education & Training
Baylor College of Medicine/Cullen Eye InstituteResidency, Ophthalmology, 2008 - 2011
University of Iowa Hospitals and ClinicsResidency, Ophthalmology, 2007 - 2010- Baylor College of MedicineInternship, Internal Medicine, 2007 - 2008
University of Florida College of MedicineClass of 2007
Certifications & Licensure
FL State Medical License 2012 - 2025
IA State Medical License 2011 - 2015- American Board of Ophthalmology Ophthalmology
Clinical Trials
- HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia Start of enrollment: 2020 Jun 12
- A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD Start of enrollment: 2021 Jul 01
Roles: Contact
Publications & Presentations
PubMed
- 22 citationsAflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.Chirag D Jhaveri, Adam R Glassman, Frederick L Ferris 3rd, Danni Liu, Maureen G Maguire, John B Allen, Carl W Baker, David Browning, Matthew A Cunningham, Scott M Frie...> ;The New England Journal of Medicine. 2022 Aug 25
- Small-Gauge Pars Plana Vitrectomy for Visually Significant Vitreous Floaters.Samantha Fink, Jaya B Kumar, Matthew A Cunningham> ;Journal of Vitreoretinal Diseases. 2020 Oct 30
- 37 citationsThe Scope Of Three-Dimensional Digital Visualization Systems In Vitreoretinal SurgeryJoshua S Agranat, John B Miller, Vivian Paraskevi Douglas, Konstantinos A A Douglas, Anna Marmalidou, Matthew A. Cunningham, Samuel K Houston> ;Clinical Ophthalmology. 2019 Oct 24
- Join now to see all
Press Mentions
Michael J. Burridge, Ph.D., Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's WhoDecember 27th, 2018
Spine Surgeon Leader to Know: Dr. Michael Hasz of Virginia Spine InstituteFebruary 13th, 2016
Hospital Affiliations
Orlando Health Orlando Regional Medical CenterOrlando, Florida
AdventHealth OrlandoOrlando, Florida
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
